KYMR
NASDAQ HealthcareKymera Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $77.50 |
|---|---|
| Volume | 647,896 |
| Market Cap | 6.33B |
| Beta | 2.300 |
| RSI (14-Day) | 32.9 |
| 200-Day MA | $60.26 |
| 50-Day MA | $79.17 |
| 52-Week High | $103.00 |
| 52-Week Low | $19.45 |
| Forward P/E | -19.29 |
| Price / Book | 3.99 |
🎯 Investment Strategy Scores
How KYMR scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
3/100
High dividend yield + low volatility
🚀 Moon Shot
96/100
High growth potential (high beta + oversold)
🔪 Falling Knife
29/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
38/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
65/100
Large-cap, institutional-quality stocks
Find KYMR in your text
Paste any text on the homepage — the tool will extract KYMR and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.